Vantage Point: Introducing the "CreaSearchers"

Share this article:

Last month in this column, Richard Vanderveer predicted that “hard” researchers exploring things like formulary decisions, access and reimbursement would be in greater demand than “soft” ones dealing with brand personalities, corporate image and the like.

Let me introduce a new kind of “soft” researcher that I predict may be in increasing demand: a “CreaSearcher,” someone who combines creative and qualitative research, bridging what has traditionally been a gap between the two. CreaSearchers recognize that qualitative is not, nor has it ever been, “research” in any scientific sense of the word.   

For decades researchers have tried to gloss over qualitative's unscientific nature by dressing it in the trappings of the scientific method. Focus groups are held in faux laboratory settings. Moderators take a passive approach, rarely interjecting their opinions. 

CreaSearchers have a different method, because they have a different goal. Their objective is not mining data, but telling stories. Their focus groups are less like therapy sessions and more like talk shows. The CreaSearcher acts as a creative guide, an imaginative peer who interjects opinions, gently points out contradictions and formalizes points of view.

The expertise for this new kind of researcher will not be the social sciences, but disciplines like journalism or screenwriting or directing.   

Driving it all will be the need for greater efficiencies, including those provided by new media technologies.

But an even larger factor may be the need for narrative in an increasingly complex and fragmented world.

In an idea-driven economy flooded with information, turning research truths into coherent stories may be what's in greatest demand of all.

David Intrator is president of Strategic Documentaries

Share this article:
close

Next Article in Vantage Point

Email Newsletters

More in Vantage Point

Vantage Point: Payers—the "experts" in healthcare research

Vantage Point: Payers—the "experts" in healthcare research

Access to payers is about knowledge, about understanding what they do in their jobs

Vantage Point: Determining "fair market value"

Vantage Point: Determining "fair market value"

Should pharma formulate a super matrix to determine the FMV of research incentives?

Vantage Point: Marketing Support for Clinical Trials

Vantage Point: Marketing Support for Clinical Trials

Pharmaceutical companies must provide robust marketing support for their clinical trials